| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| BlackRock Inc. | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 10 |
| WELLS FARGO & COMPANY/MN | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 10 |
| BOOTHBAY FUND MANAGEMENT, LLC | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 10 |
| 22NW, LP | 10 | 10 | 6.13% | 7.91% | 11.03% | Q2 2021 | Q3 2023 | 10 |
| Ikarian Capital, LLC | 10 | 10 | 0.05% | 0.11% | 0.17% | Q2 2021 | Q3 2023 | 10 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 10 |
| MANGROVE PARTNERS IM, LLC | 10 | 10 | 0.06% | 0.13% | 0.30% | Q2 2021 | Q3 2023 | 10 |
| Tower Research Capital LLC (TRC) | 7 | 2 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q3 2023 | 9 |
| UBS Group AG | 7 | 7 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2022 | 7 |
| LVW Advisors, LLC | 6 | 6 | 0.30% | 0.43% | 0.74% | Q2 2022 | Q3 2023 | 6 |
| Nantahala Capital Management | 5 | 5 | 0.08% | 0.11% | 0.13% | Q3 2022 | Q3 2023 | 5 |
| Laurion Capital Management LP | 4 | 4 | 0.01% | 0.01% | 0.02% | Q2 2021 | Q1 2022 | 4 |
| MORGAN STANLEY | 2 | 1 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2022 | 3 |
| ROYAL BANK OF CANADA | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q3 2023 | 2 |
| Praetorian PR LLC | 2 | 2 | 0.26% | 0.27% | 0.28% | Q2 2023 | Q3 2023 | 2 |
| VANGUARD GROUP INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2023 | Q3 2023 | 2 |
| OSAIC HOLDINGS, INC. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q4 2021 | 1 |
| Praetorian Capital Management LLC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2022 | Q4 2022 | 1 |
| Herr Investment Group LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q4 2022 | 1 |
| JPMORGAN CHASE & CO | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
External links
This page lists all the filers that currently own ANEBULO PHARMACEUTICALS INC or have owned ANEBULO PHARMACEUTICALS INC in the past.